The distribution of radiation throughout the body, whether in a target organ or more systemically (e.g., circulating blood), ...

Imlygic injections take about 10 minutes and are conducted over several months. In clinical trials, Dr. Gushchin says seven ...

Ricki Fairley is a Triple Negative Breast Cancer Survivor/Thriver and the CEO of TOUCH, The Black Breast Cancer Alliance. As an award-winning marketing ...

Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is ...

This week, the FDA granted approval to Sanofi SNY and Regeneron’s REGN blockbuster drug, Dupixent, for its sixth indication.

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

It has been a blockbuster year for women's health as the federal government and medtech place special focus on the wellbeing ...

Join Eyewitness News anchor Liz Cho for our annual, Emmy Award-winning WABC-TV special "Breakthroughs for Breast Cancer" on Sunday, October 13th at 5:30 p.m.

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

Researchers describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

Who needs to worry about colon cancer, and what tests will we be able to use in the future for early cancer detection?

M. Michele Blackwood, MD, FACS, provided an overview of the significant advancements with personalized medicine with genomic ...